Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy

Transplantation Proceedings

Volumn 44, Issue 1, 2012, Pages 210-213

  Yamamoto, T ^a   Kawaguchi, T ^b   Watarai, Y ^a   Tujita, M ^a   Hiramitsu, T ^a   Nanmoku, K ^a   Goto, N ^a   Katayama, A ^c   Kobayashi, T ^d   Uchida, K ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b SAKURA NATIONAL HOSPITAL   (Japan)

^c Masuko Memorial Hospital   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; BLOOD GROUP ABO INCOMPATIBILITY; CANCER RISK; CONFERENCE PAPER; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LIVING DONOR RENAL TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SPLENECTOMY;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP INCOMPATIBILITY; CHI-SQUARE DISTRIBUTION; DESENSITIZATION, IMMUNOLOGIC; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PLASMAPHERESIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPLENECTOMY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863339867     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.11.048     Document Type: Conference Paper

References (13)

1. T. Gunnar, K. Gunilla, G. Helena ABO Incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab Am J Transplant 5 2005 145
2. A. Atsushi, Y. Mioko, H. Tomomi ABO incompatible kidney transplanntationimmunological aspect Clin Transplant 2 2003 112
3. G.P. Alexandre, J.P. Squifflet, M. de Bruyere Present experiences in a series of 26 ABO-incompatible living donor renal allografts Transplant Proc 19 1987 4538
4. S.A. Grim, T. Pham, J. Thielke Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients Clin Transplant 21 2007 628
5. K. Tanabe, K. Takahashi, T. Tokumoto Infectious complications in ABO-incompatible living donor kidney transplantation: a single center experience Transplant Proc 30 1998 3130
6. B.A. Kiberd, C. Rose, J.S. Gill Cancer mortality in kidney transplantation Am J Transplant 9 2009 1846
7. E.G. Andrew, T.L. Marina, O.F. Michael Incidence of cancers in people with HIV/AJDS compared with immunosuppresed transplant recipients: a meta-analysis Lancet 370 2007 59
8. A.I. Dipchand, S.M. Pollock BarZiv, C. Manlhiot Equivalent outcomes for pediatric heart transplantation recipients: ABOblood group incompatible versus ABO-compatible Am J Transplantation 10 2010 387
9. A.C. Webster, J.C. Craig, J.M. Simpson Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15183 recipients Am J Transplant 7 2007 2140
10. J.B. Peter, V. Amy, R. Mindi Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia Int J Toxicol 29 2010 435
11. E. Denpanich, L. Kasiske Risk factors for cancer in renal transplant recipients Transplantation 68 1999 1859
12. D. Chen, Asamura Kikuchi Evaluation of mizoribine as an immunosuppressant in subrenal capsule assay using immunocompetent mice Jpn Cancer Res 81 1990 183
13. M. Yun, J.E. Jason, G.G. Thomas De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population Transplantation 87 2009 1347